| September 12, 2005
Corrected |
|
|||||||||||||||||||||||||||||||||||||||||
| Travel Fee Calculator | ||||||||||||||||||||||||||||||||||||||||||
|
XIFIN is pleased to announce the addition of a Travel Fee Calculator to its Lab Resources. In 1998 HCFA altered submission guidelines and reimbursement criteria for travel allowance. Labs may bill a pro-rated flat fee for total miles traveled when mileage is less than 20; and a pro-rated flat fee or a per mile fee when the total mileage is greater than 20. To assist labs in determining which option best maximizes reimbursable travel fees, XIFIN makes a calculator available on our website for your use and reference. XIFIN Lab Resources Travel Fee Calculator. |
||||||||||||||||||||||||||||||||||||||||||
| CCI Updates | ||||||||||||||||||||||||||||||||||||||||||
CMSMedlearn Matters MM3995
Quarterly Update to Correct Coding Initiative (CCI) edits The next update of CCI edits will be effective on October 01, 2005. CCI edits and Mutually Exclusive Code (MEC) edits are available on the CMS web site. The web site will be updated with the Version 11.3 edits as soon as they are effective. |
||||||||||||||||||||||||||||||||||||||||||
| Carrier Manual Update | ||||||||||||||||||||||||||||||||||||||||||
CMSTransmittal 643 CR 3897
Carrier Manual Update to Assignment on Carrier Claims In “mandatory assignment” situations, i.e., where payment under the Act can be made only on an assignment-related basis to the supplier, the beneficiary (or the person authorized to request payment on the beneficiary’s behalf) is not required to assign the claim to the supplier in order for an assignment to be effective. However, the beneficiary (or the person authorized to request payment on the beneficiary’s behalf) must continue to authorize the release of medical or other information necessary to process the claim and request payment of Medicare benefits for the Medicare Part B covered services pursuant to 42 C.F.R 424.32 and 424.36 (see also Pub. 100-04, ch. 1, sect. 50.1). Physicians or suppliers who agree to (or must by law) accept assignment from Medicare cannot attempt to collect more than the appropriate Medicare deductible and coinsurance amounts from the beneficiary, his/her other insurance, or anyone else. |
||||||||||||||||||||||||||||||||||||||||||
| CWF Update | ||||||||||||||||||||||||||||||||||||||||||
CMSMedlearn Matters MM3946
Update to Medicare's Duplicate Claims Edit for Clinical Diagnostic Services in the Common Working File (CWF) The Centers for Medicare & Medicaid Services (CMS) issued CR 3551, Transmittal 124, on October 29, 2004, to implement a new edit in Medicare’s systems, effective April 01, 2005, to check for duplicate claims for referred clinical diagnostic laboratory services and purchased diagnostic services submitted by physicians/supplier to more than one carrier. This edit for clinical diagnostic laboratory services and purchased diagnostic claims, which was implemented on April 04, 2005, did not edit line items that contained the “90” modifier. When performing the data matching, the Medicare duplicate claim edit for referred clinical diagnostic laboratory performed the matching on the claim fields: (a) Beneficiary Name; (b) Beneficiary Health Insurance Claim Number (HICN); (c) Current Procedural Terminology (CPT)/Healthcare Common Procedure Coding System (HCPCS) code; (d) Date of Service; and (e) CPT/HCPCS Code Modifier. That edit was not applied to claims with a “90” modifier. Medicare will modify the duplicate claim edit to reject all clinical laboratory services submitted to carriers when it has been determined that another carrier has already paid for the same service on the same date of service, with the exception of those claims containing the “91” modifier. This modified edit will apply to all laboratory claims with dates of service on or after January 01, 2006. When claims are denied as a result of this edit, Medicare carriers will use remark code N347 on the remittance advice to show “Your claim for a referred or purchased service cannot be paid because payment has already been made for this same service to another provider by a payment contractor representing the payer.” Note: Repeat clinical laboratory services for the same beneficiary on the same date of service are identified by the “91” modifier. When performing the data matching, the CWF duplicate claim edit for referred clinical diagnostic laboratory service will not include the “91” modifier on referred laboratory claims in the matching criteria, but will perform matching on all others as specified above. |
||||||||||||||||||||||||||||||||||||||||||
| New FDA Waived Tests | ||||||||||||||||||||||||||||||||||||||||||
CMSMedlearn Matters CR 3984
The following tests are approved by the FDA as waived tests under the CLIA.
Note: The tests mentioned on the first page of the Attachment included with CR3984 (i.e., CPT codes: 81002, 81025, 82270, G0107, 82962, 83026, 84830, 85013, and 85651) do not require a QW modifier to be recognized as a waived test. |
||||||||||||||||||||||||||||||||||||||||||
| Modifiers to AMCC Tests Submitted for ESRD Patients | ||||||||||||||||||||||||||||||||||||||||||
CMSMedlearn Matters MM3890
The ESRD 50/50 rule requires the billing laboratory to determine (for the same beneficiary on the same date-of-service):
The proportion of composite versus non-composite tests calculated by the billing laboratory is then used to determine whether separate payment may be made for all tests performed on that day. Effective January 1, 2006, when billing for AMCC tests for an ESRD patient, the laboratory must identify the appropriate modifier for each test, as follows:
|
||||||||||||||||||||||||||||||||||||||||||
| Changes to NCDs | ||||||||||||||||||||||||||||||||||||||||||
CMSMedlearn Matters CR 4005
CR4005 announces changes to the list of codes included in the October 2005 release of the Medicare Laboratory National Coverage Determination (NCD) edit module for clinical diagnostic laboratory services. These changes are a result of new ICD-9-CM code changes that become effective October 01, 2005. Urine Culture
Immunodeficiency Virus (HIV) Testing (Diagnosis)
Blood Counts
Partial Thromboplastin Time (PTT)
Prothrombin Time (PT)
Serum Iron Studies
Blood Glucose Testing
Thyroid Testing
Lipid Testing
Digoxin Therapeutic Drug Assay
Prostate Specific Antigen Testing
Gamma Glutamyl Transferase Testing
Fecal Occult Blood Testing
Negotiated Laboratory NCDs
|
||||||||||||||||||||||||||||||||||||||||||
| Medicare Physicians Fee Schedule Update | ||||||||||||||||||||||||||||||||||||||||||
CMSCMS Manual System CR4031
CR4031 amends payment files issued to Medicare carriers and intermediaries based upon the November 15, 2004, Final Rules for the 2005 Medicare Physician Fee Schedule Database. The changes to the fee schedule involve numerous CPT/HCPCS codes. While many of these changes are effective retroactive to January 1, 2005, please note that your carrier/FI will not reprocess claims already processed, unless you request them to do so. The complete details of these changes to the October update to the 2005 Medicare Fee Schedule Database are described in an attachment to CR 4031, which is the official instruction issued to your carrier/intermediary. That instruction may be viewed by selecting the link above for the CMS web site. |
|
|
||
| Contact Us | Privacy Statement | Legal | ||
| ©2005 XIFIN®, Inc. All rights reserved. | ||